Pioneering RNA Cell Therapy for Autoimmune Diseases
Time: 11:00 am
day: Conference Day Two
Details:
- Developing the first RNA cell therapy in an autoimmune disease, Descartes-08
- Sharing long-term follow-up data from the phase 1/2a open-label trial in patients with myasthenia gravis
- Discussing the next steps for Descartes-08 in myasthenia gravis and other autoimmune indications
